Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers
- PMID: 7000717
Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers
Abstract
The bioavailability, plasma levels and pharmacological effect of a daily dose of 0.2 g of metoprolol in Durules and in regular 0.1 g tablets have been studied in eight healthy volunteers during steady state conditions. Durules and two 0.1 g metoprolol tablets were given once daily, and one 0.1 g metoprolol tablet was given every 12th hour. The maximum concentration of metoprolol in plasma after Durules was about half of that after two regular tablets. When one metoprolol 0.1 g tablet was administered every 12th hour, an average maximum concentration slightly higher than for the Durules was recorded about one hour after the administration. The minimum concentration of metoprolol during the day was about twice as high after Durules as after the same dose in regular tablets. The dose-corrected area under the plasma concentration vs time curve of Durules was 87 per cent of the b.i.d. regimen of metoprolol in regular tablets and about 75 per cent of two metoprolol 0.1 g tablets once daily. Metoprolol Durules maintained a more even effect on heart rate and systolic blood pressure during exercise during the day than the corresponding daily dose of metoprolol given as two metoprolol 0.1 g tablets once daily or as one metoprolol 0.1 g tablet every 12th hour. After maximum beta-blockade the effect declined by, on average, 0.60 per cent/hour for the Durules and 0.96 per cent for the regular tablet. The exercise heart rate before the morning dose was significantly lower during treatment with Durules and one metoprolol 0.1 g tablet b.i.d. than during the placebo period. The interaction of metoprolol with the effect of adrenaline (0.09 microgram x kg-1 x min-1, infused at 2, 3.5 and 5 hrs after metoprolol administration) on the diastolic blood pressure was more pronounced when two ordinary 0.1 g metoprolol tablets were administered once daily than for the corresponding dose in Durules, this probably reflecting a difference in degree of action of metoprolol on the vascular bed for Durules and regular metoprolol tablets in identical doses.
Similar articles
-
Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.Ann Clin Res. 1979 Oct;11(5):199-204. Ann Clin Res. 1979. PMID: 44671 Clinical Trial.
-
Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.Ann Clin Res. 1981;13 Suppl 30:30-6. Ann Clin Res. 1981. PMID: 7027891 Clinical Trial.
-
Treatment of angina pectoris with metoprolol. A comparison between Durules administered once daily and tablets administered twice daily.Ann Clin Res. 1981;13 Suppl 30:58-60. Ann Clin Res. 1981. PMID: 6794419 Clinical Trial.
-
Treatment with beta-blockers--the value of an even plasma concentration over 24 h.J Clin Pharm Ther. 1997 Jun;22(3):171-9. doi: 10.1046/j.1365-2710.1997.8775087.x. J Clin Pharm Ther. 1997. PMID: 9447471 Review.
-
Achieving optimal beta1-blockade with metoprolol CR/Zok.Basic Res Cardiol. 2000;95 Suppl 1:I46-51. doi: 10.1007/s003950070009. Basic Res Cardiol. 2000. PMID: 11192353 Review.
Cited by
-
Oxidation phenotype and the metabolism and action of beta-blockers.Klin Wochenschr. 1985 Apr 1;63(7):285-92. doi: 10.1007/BF01731972. Klin Wochenschr. 1985. PMID: 2860267 Review.
-
Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.Drugs. 1986 May;31(5):376-429. doi: 10.2165/00003495-198631050-00002. Drugs. 1986. PMID: 2940080 Review.
-
Slow release beta-adrenoceptor blocking drugs.J R Coll Physicians Lond. 1983 Apr;17(2):126-32. J R Coll Physicians Lond. 1983. PMID: 6132994 Free PMC article. No abstract available.
-
Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications.Clin Pharmacokinet. 1991 Nov;21(5):319-30. doi: 10.2165/00003088-199121050-00001. Clin Pharmacokinet. 1991. PMID: 1773547 Review.
-
Genetically determined adverse drug reactions involving metabolism.Drug Saf. 1993 Jul;9(1):60-77. doi: 10.2165/00002018-199309010-00006. Drug Saf. 1993. PMID: 8347292 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous